#1 Clinical Trials Search in Europe

Levocabastine Hydrochloride

This article explores the use of Levocabastine Hydrochloride in clinical trials for the treatment of allergic rhinitis. Levocabastine is an antihistamine medication that has been studied alone and in combination with other drugs to assess its effectiveness in managing nasal and ocular symptoms associated with allergic rhinitis. The trials discussed here aim to evaluate the efficacy, safety, and optimal dosing of Levocabastine compared to placebos and other treatments.

Table of Contents

What is Levocabastine?

Levocabastine hydrochloride, also known simply as levocabastine, is a medication primarily used to treat allergic rhinitis, which is a type of inflammation in the nose caused by allergies[1]. It belongs to a class of drugs called antihistamines, which work by blocking the effects of histamine, a substance your body produces during an allergic reaction[2].

Medical Conditions Treated

Levocabastine is primarily used to treat the following conditions:

  • Allergic Rhinitis: This includes both perennial (year-round) and seasonal allergic rhinitis, commonly known as hay fever[1][3].
  • Nasal Symptoms: It helps alleviate symptoms such as nasal congestion, runny nose, nasal itching, and sneezing[1].
  • Ocular Symptoms: Some studies have also evaluated its effect on eye-related allergy symptoms like red, itchy, and tearing eyes[1].

How It Works

Levocabastine is an antihistamine that works by blocking histamine receptors in the body. When you’re exposed to an allergen (like pollen or dust), your body releases histamine, which causes allergy symptoms. By blocking the histamine receptors, levocabastine helps reduce these symptoms[2].

Administration

Levocabastine is typically administered as a nasal spray. The usual dosage is:

  • Two sprays in each nostril, either once daily (in the morning) or twice daily (morning and evening)[1][3].
  • The medication is usually supplied as an intranasal aqueous microsuspension (a type of liquid mixture) in an amber glass bottle with a special spray pump[1].
  • It’s often administered in a fasted state, meaning you should use it before eating[1].

Clinical Studies

Several clinical trials have been conducted to evaluate the efficacy of levocabastine:

  • Environmental Exposure Chamber (EEC) Studies: These studies use a special chamber where allergens are released to test how well the medication works. Researchers measure symptoms before and after exposure to allergens[1][3].
  • Symptom Scoring: Researchers use various scoring systems to measure the effectiveness of the medication, including:
    • Total Nasal Symptom Score (TNSS): This measures nasal congestion, runny nose, nasal itching, and sneezing[1].
    • Total Ocular Symptom Score (TOSS): This measures eye-related symptoms[1].
  • Duration of Studies: Clinical trials typically last several weeks, with some studies extending up to 20 weeks[1].

Combination Therapy

Some studies have investigated the use of levocabastine in combination with other medications:

  • Fluticasone Furoate (FF): This is a corticosteroid that has been studied in combination with levocabastine for treating allergic rhinitis[1].
  • Mometasone Furoate: Another corticosteroid that has been studied in combination with levocabastine[2].
  • Budesonide: Some studies have looked at combining levocabastine with budesonide, another type of corticosteroid nasal spray[4].

These combination therapies aim to provide better symptom relief than either medication alone, but more research is needed to fully understand their benefits and risks.

Side Effects and Safety

While specific side effects weren’t detailed in the provided clinical trial information, it’s important to note that all medications can have potential side effects. Common side effects of nasal sprays may include:

  • Nasal irritation
  • Dry nose
  • Sneezing
  • Headache

Always consult with your healthcare provider about potential side effects and safety considerations before starting any new medication[4].

Aspect Details
Study Types Randomized, double-blind, placebo-controlled, crossover studies
Primary Objectives Evaluate efficacy of Levocabastine alone and in combination with other drugs for allergic rhinitis
Dosage Forms Intranasal aqueous microsuspension, typically 50 mcg per spray
Dosing Regimens Once daily (QD) or twice daily (BID), usually two sprays per nostril
Outcome Measures Total Nasal Symptom Score (TNSS), Total Ocular Symptom Score (TOSS)
Evaluation Methods Allergen challenge chambers, symptom diaries, physician assessments
Combination Therapies Levocabastine with Fluticasone Furoate or Mometasone Furoate
Study Duration Varies, ranging from 4 weeks to 20 weeks including follow-up

FAQ

  • What is Levocabastine Hydrochloride? Levocabastine Hydrochloride is an antihistamine medication used to treat symptoms of allergic rhinitis, such as sneezing, runny nose, and nasal itching. It is typically administered as a nasal spray.
  • How is Levocabastine being studied in clinical trials? Levocabastine is being studied alone and in combination with other drugs like Fluticasone Furoate or Mometasone Furoate. Trials are comparing its effectiveness to placebos and other treatments, as well as evaluating different dosing regimens (once daily vs. twice daily).
  • What are the main symptoms that Levocabastine targets? Levocabastine primarily targets nasal symptoms of allergic rhinitis, including nasal congestion, rhinorrhea (runny nose), nasal itching, and sneezing. Some studies also evaluate its effect on ocular symptoms like red, itchy, and tearing eyes.
  • How is the effectiveness of Levocabastine measured in these trials? The effectiveness is mainly measured using symptom scores such as the Total Nasal Symptom Score (TNSS) and Total Ocular Symptom Score (TOSS). These scores are often assessed in allergen challenge chambers, where participants are exposed to allergens in a controlled environment.
  • Are there any side effects or safety concerns associated with Levocabastine use? While the trials mentioned focus primarily on efficacy, they also evaluate the safety and tolerability of Levocabastine. However, specific side effects are not detailed in the provided information. As with any medication, it's important to discuss potential side effects with a healthcare provider.

Ongoing Clinical Trials on Levocabastine Hydrochloride

  • Evaluation of Alutard SQ dog allergen immunotherapy in patients with allergic rhinitis due to dog allergy – A one-year study in Swedish practice

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany

Glossary

  • Allergic Rhinitis: An inflammation of the nasal passages caused by an allergic reaction, resulting in symptoms such as sneezing, runny nose, and nasal congestion.
  • Levocabastine Hydrochloride: An antihistamine medication used to treat symptoms of allergic rhinitis, typically administered as a nasal spray.
  • Total Nasal Symptom Score (TNSS): A measure used to assess the severity of nasal symptoms in allergic rhinitis, including nasal congestion, rhinorrhea, nasal itching, and sneezing.
  • Total Ocular Symptom Score (TOSS): A measure used to assess the severity of eye symptoms associated with allergic rhinitis, including redness, itching, and tearing.
  • Environmental Exposure Chamber (EEC): A controlled setting where participants are exposed to specific allergens to evaluate the effectiveness of allergy treatments.
  • Fixed Dose Combination (FDC): A combination of two or more active pharmaceutical ingredients combined in a single dosage form.
  • Placebo: An inactive substance used in clinical trials to compare the effects of a medication against a non-active treatment.
  • Rhinorrhea: Excessive discharge of thin nasal fluids, commonly known as a runny nose.
  • Fluticasone Furoate (FF): A corticosteroid medication used to treat allergic rhinitis and asthma symptoms.
  • Mometasone Furoate: A corticosteroid medication used to treat inflammation and allergic responses in the nose.

References

  1. https://clinicaltrials.gov/study/NCT01957202
  2. https://clinicaltrials.gov/study/NCT02498509
  3. https://clinicaltrials.gov/study/NCT01949051
  4. https://clinicaltrials.gov/study/NCT04002349